Ins 18.12(1)(e)
(e) Procedures for consideration of pertinent information for cases referred to independent review organizations regarding an adverse determination, including all of the following:
Ins 18.12(1)(e)4.
4. Information accumulated regarding the case prior to its referral to independent review, including the rationale for prior review determinations.
Ins 18.12(1)(e)5.
5. Information submitted to the independent review organization by the referring entity, insured or attending provider.
Ins 18.12(1)(e)7.
7. Medical or scientific evidence including evidence that is determined to be an efficacious treatment or strategy as defined at
s. Ins 3.36 (3) (c), as appropriate.
Ins 18.12(1)(f)
(f) Procedures for consideration of pertinent information for cases referred to the independent review organization regarding experimental treatment determinations including all information required in
par. (e) and existing medical or scientific evidence regarding the proposed treatment with respect to effectiveness and efficacy.
Ins 18.12(1)(g)
(g) Policies and procedures to request and accept any additional information that may assist in rendering a determination. Information received by the independent review organization from the insured or attending provider shall be provided to the insurer offering a health benefit plan in order to provide the insurer with the opportunity to reverse its decision.
Ins 18.12(1)(h)
(h) Procedures to ensure that within 2 business days of rendering a determination, the independent review organization shall, in addition to the requirements of s.
632.835 (3) (f), Stats., send to the insurer offering a health benefit plan, the insured, or the insured's authorized representative a written notice of the determination that includes all of the following:
Ins 18.12(1)(h)2.
2. A description of the qualifications of the reviewer or reviewers.
Ins 18.12(1)(h)3.
3. A clinical rationale or explanation for the independent review organization's determination, including supporting evidence and a clear statement of the decision.
Ins 18.12(1)(h)4.
4. The decision shall be signed by the case reviewer or, in cases where more than one reviewer is assigned to review the case, the signature of at least one of the reviewers.
Ins 18.12(1)(i)
(i) Procedures to ensure expedited reviews are completed in accordance with s.
632.835 (3) (g), Stats., and take into account the insured's health condition. Upon completion of the review, the independent review organization shall provide its decision within one hour, or as expeditiously as practicable, to the insured, or the insured's authorized representative, and the insurer.
Ins 18.12(1)(j)
(j) Procedures to ensure that the decision of the independent review organization is consistent with s.
632.835 (3m), Stats.
Ins 18.12(1)(k)
(k) Procedures for determining when the inclusion of an attorney or actuary as a member of a review panel or the advice of an attorney and actuary would provide appropriate and necessary assistance in the review.
Ins 18.12(2)
(2) Quality assurance procedures. Independent review organizations shall establish, maintain and demonstrate compliance with written quality assurance procedures that promote objective and systematic monitoring and evaluation of the independent review process and that includes, at a minimum, all procedures to ensure the following:
Ins 18.12(2)(a)
(a) That the independent reviews are conducted within the specified time frames and that required notices are provided in a timely manner.
Ins 18.12(2)(b)
(b) That the selection of qualified and impartial clinical peer reviewers to conduct independent reviews on behalf of the independent review organization is achieved, including that the matching of reviewers to specific cases is suitable.
Ins 18.12(2)(c)
(c) The independent review organization shall conduct appropriate training, monitor performance on an ongoing basis and evaluate, no less than annually, each of the reviewers and non-clinical staff.
Ins 18.12(2)(d)
(d) That the confidentiality of personal medical information is maintained in accordance with state and federal law. Access to personal medical information shall be limited to only the information necessary for review of the services under independent review, used solely for the purpose of independent review and shared only with the selected reviewers, the insurer and the insured or the insured's authorized representative.
Ins 18.12(2)(e)
(e) That any person employed by, or under contract with, the independent review organization adheres to the requirements of this section.
Ins 18.12(2)(f)
(f) That management reports are adequate to track and monitor matters described in
pars. (a) to
(e).
Ins 18.12(3)(a)(a) The independent review organization shall establish a toll-free telephone service to receive information on a 24-hour, 7-days per week, basis. The telephone service selected shall be capable of accepting, recording or providing appropriate instruction to incoming telephone callers during other than normal business hours.
Ins 18.12(3)(b)
(b) The independent review organization shall establish policies and procedures to ensure that services are provided during times other than normal business hours to ensure that the independent review organization meets its obligation under
sub. (1) (i).
Ins 18.12(4)(a)(a) In addition to the requirements of s.
632.835 (6m), Stats., the independent review organization shall require all clinical peer reviewers assigned to conduct independent reviews to be physicians or other appropriate health care providers whose qualifications are verified at least every 2 years.
Ins 18.12(4)(b)
(b) For coverage denial determinations that include a legal review, the independent review organization shall require legal reviewers assigned to conduct independent reviews be attorneys licensed and in good standing in this state and whose qualifications are verified at least every 2 years.
Ins 18.12(4)(c)
(c) For coverage denial determinations that include review of an underwriting determination, the independent review organization shall require actuaries be assigned to assist in the review and be a member in good standing of the American academy of actuaries and whose qualifications are verified at least every 2 years.
Ins 18.12(5)
(5) Conflict of interest. In addition to the requirements in s.
632.835 (6), Stats., all clinical peer, legal and actuary reviewers shall, at least quarterly, provide to the independent review organization a list of potential conflicts of interest.
Ins 18.12(6)(a)(a) Except as provided in
par. (b), an independent review organization shall employ or contract with a medical director with professional post-residency experience in direct patient care who holds a current license to practice medicine and who has a clinical specialty appropriate to the type of reviews conducted by the independent review organization.
Ins 18.12(6)(b)
(b) An independent review organization that limits its reviews to matters related to a particular type of health care may employ or contract with a clinical director. The clinical director shall be trained and hold a current license in a medical or health care specialty appropriate to the full scope of the organization's review.
Ins 18.12(6)(c)
(c) The independent review organization shall require the medical director or clinical director to oversee the medical or
health care aspects of quality assurance and credentialing programs.
Ins 18.12(6m)
(6m) An independent review organization may employ or contract with a law firm, experienced attorney, actuarial entity or experienced actuary to assist in the review of matters related to reformations, rescissions and preexisting condition denial determinations. The independent review organization shall oversee aspects of quality assurance, licensing and expertise of the legal or actuarial reviewer.
Ins 18.12(7)
(7) Delegated functions. The independent review organization may delegate or subcontract review functions. Nevertheless, the independent review organization is responsible for the delegated or subcontracted functions, including any violation of law, policy or procedure. In addition, an independent review organization that delegates or subcontracts independent review functions shall provide documentation and verification of all of the following:
Ins 18.12(7)(a)
(a) Written contracts with the subcontractor that delineates with specificity all duties and responsibilities.
Ins 18.12(7)(b)
(b) A review by the independent review organization, on at least an annual basis, of the subcontractor's policies, procedures, and quality assurance program, if relevant to the subcontracted functions.
Ins 18.12(7)(c)
(c) A review by the independent review organization, on at least an annual basis, of the subcontractor's performance and compliance, monitored by the independent review organization, with stated policies, procedures, quality assurance programs and applicable laws.
Ins 18.12(7)(d)
(d) A review by the independent review organization, on at least an annual basis, of the effectiveness of communication and coordination of processes between the independent review organization and the subcontractor.
Ins 18.12(8)
(8) Unbiased. An independent review organization shall be unbiased. An independent review organization shall establish and maintain procedures to ensure that it is unbiased.
Ins 18.12 History
History: CR 00-169: cr.
Register November 2001 No. 551, eff. 12-1-01;
CR 04-079: am. (1) (b)
Register December 2004 No. 588, eff. 1-1-05;
CR 10-023: am. (1) (b) 1., 2., (e) 7., (4), (5), cr. (1) (e) 8., (k), (6m) Register September 2010 No. 657, eff. 10-1-10. Ins 18.13
Ins 18.13 Standards of independent review. Ins 18.13(1)
(1) For coverage denial determinations other than experimental treatment determinations, independent review organizations shall consider any of the following:
Ins 18.13(1)(a)
(a) Medical or scientific evidence including evidence that is determined to be an efficacious treatment or strategy as defined at
s. Ins 3.36 (3) (c).
Ins 18.13(2)
(2) Independent review organizations shall include as members or advisors an attorney or actuary when the dispute involves a rescission, reformation or the dispute includes a legal dispute. The addition of an attorney or actuary to a review panel is at the discretion of the independent review organization or reviewers and need only be considered when the independent review organization or reviewers determine additional expertise would provide appropriate and necessary assistance in the review.
Ins 18.13 History
History: CR 10-023: cr. Register September 2010 No. 657, eff. 10-1-10. Ins 18.14
Ins 18.14 Approval of independent review organizations. Ins 18.14(1)(1) In addition to meeting the requirements established s.
632.835 (4) (a), Stats., any independent review organization seeking approval to conduct independent reviews shall submit an application for approval on a form prescribed by the commissioner and include with the form all documentation and information necessary for the commissioner to determine if the independent review organization is unbiased and satisfies
s. Ins 18.12.
Ins 18.14(2)
(2) The independent review organization shall submit informational materials to the commissioner as part of the application. Materials will be maintained in the office for public review.
Ins 18.14(3)
(3) The independent review organization shall submit the application fee in accordance with s.
601.31 (1) (Lp), Stats., at the time of the application to an identified lock box address.
Ins 18.14 History
History: CR 00-169: cr.
Register November 2001 No. 551, eff. 12-1-01.
Ins 18.16
Ins 18.16 Independent review organization reporting requirements. Ins 18.16(1)(1) An independent review organization shall maintain records on all independent review activity during each calendar year and submit a report to the commissioner, on a form prescribed by the commissioner, by March 1 of each year for the prior calendar year's experience. Records shall be maintained so that, at a minimum, they satisfy the reporting requirements to the commissioner and shall be retained for at least 3 years.
Ins 18.16(2)
(2) The annual report shall include all of the following information on an aggregate basis, by insurer and by insurer and insurance product name:
Ins 18.16(2)(a)
(a) The total number of requests for independent review received.
Ins 18.16(2)(b)
(b) The total number of requests for independent review declined and the reason for the declination, including whether the request was a qualified request or within the scope of the health benefit plan policy.
Ins 18.16(2)(c)
(c) The total number of requests for expedited independent review that the independent review organization declined to handle in an expedited timeframe, including whether the request was a qualified request or within the scope of the health benefit plan policy.
Ins 18.16(2)(d)
(d) The number of independent reviews that were done in an expedited manner and the results of those reviews.
Ins 18.16(2)(e)
(e) The number of requests for independent review resolved and, of those resolved, the number resolved upholding the coverage denial determination by the insurer and the number resolved reversing the coverage denial determination by the insurer.
Ins 18.16(2)(em)
(em) The names and specialty of the reviewers participating in reviews conducted during the year. The listing shall include the name of any attorney or actuary or the respective firm, who participated in the reviews.
Ins 18.16(2)(g)
(g) A detailed summary of cases including a synopsis of facts, rationale for decision and key evidence relied upon to reach the reviewer's decision. The summary shall also include the types of cases or coverage for which an independent review was sought.
Ins 18.16(2)(h)
(h) The cost of reviews both in the aggregate and on a case by case basis.
Ins 18.16(2)(i)
(i) The number of independent reviews that were terminated as the result of reconsideration by the insurer offering a health benefit plan of its coverage denial determination after the receipt of additional information from the insured, the insured's authorized representative, or other appropriate sources.
Ins 18.16 History
History: CR 00-169: cr.
Register November 2001 No. 551, eff. 12-1-01;
CR 10-023: am. (2) (e), (i), cr. (2) (em) Register September 2010 No. 657, eff. 10-1-10.
Ins 18.18
Ins 18.18 Independent review organization fees. Ins 18.18(1)(1) A certified independent review organization shall submit its fee schedule in accordance with s.
632.835 (4) (ap), Stats., to the commissioner for review and approval.
Ins 18.18(2)
(2) Fee schedules shall be based on prevailing rates in the industry demonstrated by supporting credible documentation including actual costs for conducting the reviews. Fee schedules shall be on a per case basis according to categories established by the commissioner. The fee schedule shall include a category for the fee payable for a review that is terminated because the insurer voluntarily reverses its decision because of information first received by the insurer after the review is requested.
Ins 18.18(3)
(3) An insurer offering a health benefit plan shall pay the fee submitted by the independent review organization within 30 days of receipt of a written invoice or billing record from the independent review organization.
Ins 18.18(4)
(4) The independent review organization may only charge the fees in accordance with the fee schedule that is approved by the commissioner.
Ins 18.18(6)
(6) If an independent review organization determines the matter is not within its authority to review, it may not charge for that determination.
Ins 18.18 History
History: CR 00-169: cr.
Register November 2001 No. 551, eff. 12-1-01;
CR 10-023: r. (5), am. (6) Register September 2010 No. 657, eff. 10-1-10.
